These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 17473196

  • 21. Correlation of gamma-catenin expression with good prognosis in medulloblastomas.
    Misaki K, Marukawa K, Hayashi Y, Fukusato T, Minamoto T, Hasegawa M, Yamashita J, Fujisawa H.
    J Neurosurg; 2005 Mar; 102(2 Suppl):197-206. PubMed ID: 16156230
    [Abstract] [Full Text] [Related]

  • 22. p73 expression in medulloblastoma: TAp73/DeltaNp73 transcript detection and possible association of p73alpha/DeltaNp73 immunoreactivity with survival.
    Zitterbart K, Zavrelova I, Kadlecova J, Spesna R, Kratochvilova A, Pavelka Z, Sterba J.
    Acta Neuropathol; 2007 Dec; 114(6):641-50. PubMed ID: 17912537
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior.
    Min HS, Lee YJ, Park K, Cho BK, Park SH.
    Acta Neuropathol; 2006 Jul; 112(1):13-20. PubMed ID: 16691420
    [Abstract] [Full Text] [Related]

  • 26. [Comparative genomic classification of human hepatocellular carcinoma].
    Kaposi-Novák P.
    Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
    [Abstract] [Full Text] [Related]

  • 27. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [Abstract] [Full Text] [Related]

  • 28. An immunohistochemical analysis of medulloblastoma and PNET with emphasis on N-myc protein expression.
    Moriuchi S, Shimizu K, Miyao Y, Hayakawa T.
    Anticancer Res; 1996 Dec; 16(5A):2687-92. PubMed ID: 8917371
    [Abstract] [Full Text] [Related]

  • 29. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.
    von Bueren AO, Shalaby T, Rajtarova J, Stearns D, Eberhart CG, Helson L, Arcaro A, Grotzer MA.
    BMC Cancer; 2007 Jan 25; 7():19. PubMed ID: 17254356
    [Abstract] [Full Text] [Related]

  • 30. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
    Pan E, Pellarin M, Holmes E, Smirnov I, Misra A, Eberhart CG, Burger PC, Biegel JA, Feuerstein BG.
    Clin Cancer Res; 2005 Jul 01; 11(13):4733-40. PubMed ID: 16000568
    [Abstract] [Full Text] [Related]

  • 31. Quantitative mRNA expression analysis of neurotrophin-receptor TrkC and oncogene c-MYC from formalin-fixed, paraffin-embedded primitive neuroectodermal tumor samples.
    Kunz F, Shalaby T, Lang D, von Büren A, Hainfellner JA, Slavc I, Tabatabai G, Grotzer MA.
    Neuropathology; 2006 Oct 01; 26(5):393-9. PubMed ID: 17080715
    [Abstract] [Full Text] [Related]

  • 32. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 01; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 33. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma.
    Pingoud-Meier C, Lang D, Janss AJ, Rorke LB, Phillips PC, Shalaby T, Grotzer MA.
    Clin Cancer Res; 2003 Dec 15; 9(17):6401-9. PubMed ID: 14695141
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A prospective analysis of c-myc oncoprotein levels as a prognostic marker in malignant melanoma.
    Ramsden AJ, Grover R, Chana J, Tulley P, Sanders R, Wilson GD.
    J Plast Reconstr Aesthet Surg; 2007 Dec 15; 60(6):626-30. PubMed ID: 17485049
    [Abstract] [Full Text] [Related]

  • 36. c-myc overexpression causes anaplasia in medulloblastoma.
    Stearns D, Chaudhry A, Abel TW, Burger PC, Dang CV, Eberhart CG.
    Cancer Res; 2006 Jan 15; 66(2):673-81. PubMed ID: 16423996
    [Abstract] [Full Text] [Related]

  • 37. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
    Dome JS, Bockhold CA, Li SM, Baker SD, Green DM, Perlman EJ, Hill DA, Breslow NE.
    J Clin Oncol; 2005 Dec 20; 23(36):9138-45. PubMed ID: 16172460
    [Abstract] [Full Text] [Related]

  • 38. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.
    Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R, Ernestus K, König R, Haas S, Eils R, Schwab M, Brors B, Westermann F, Fischer M.
    J Clin Oncol; 2006 Nov 01; 24(31):5070-8. PubMed ID: 17075126
    [Abstract] [Full Text] [Related]

  • 39. The c-myc proto-oncogene in invasive carcinomas of the uterine cervix: clinical relevance of overexpression in early stages of the cancer.
    Riou GF, Bourhis J, Le MG.
    Anticancer Res; 1990 Nov 01; 10(5A):1225-31. PubMed ID: 2173473
    [Abstract] [Full Text] [Related]

  • 40. Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue.
    Hartmann E, Fernàndez V, Moreno V, Valls J, Hernández L, Bosch F, Abrisqueta P, Klapper W, Dreyling M, Hoster E, Müller-Hermelink HK, Ott G, Rosenwald A, Campo E.
    J Clin Oncol; 2008 Oct 20; 26(30):4966-72. PubMed ID: 18606985
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.